-
-
-
-
-
-
-
ADC Therapeutics SA (ADCT) Tops Q2 EPS by 14c
-
-
-
-
-
-
-
ADC Therapeutics SA (ADCT) Announces Presentation of LOTIS-7 Clinical Trial Data
-
-
-
-
-
-
-
ADC Therapeutics (ADCT) Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cel
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

